Kin Man Au, Ph.D. Assistant Professor School Medical School Department Radiation Oncology Graduate Programs Biomedical Engineering Biography Kin Man Au, Ph.D., is an Assistant Professor of Radiation Oncology at UT Southwestern Medical Center. He is part of the Department of Radiation Oncology’s Section of Molecular Medicine. Dr. Man Au earned a master’s degree in chemistry at the University of Sheffield (UK) in 2007. He also attended graduate school there and received a Ph.D. in chemistry in 2013. His Ph.D. thesis was titled, Biomedical Applications of Polypyrrole Nanoparticles. Afterward, Dr. Man Au completed his postdoctoral research at the University of North Carolina at Chapel Hill and then accepted a faculty position at UT Southwestern Medical Center. His research interests include cancer, drug delivery, polymer chemistry, biomedical imaging, photothermal therapy, radiotherapy and nuclear medicine, and cancer immunotherapy. Research Interest Autoimmune diseases Biomaterials Biomedical imaging Cancer Cancer immunotherapy Chemoradiotherapy adoptive cell therapy Chemotherapy Drug delivery In vivo animal model Low-cost point-of-care diagnostic test Photothermal therapy Polymer chemistry Radiotherapy and nuclear medicine Publications An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis Au KM, Wilson JE, Ting JP, Wang AZ Nature Biomedical Engineering 2024 Oct 8 1243-1265 Correction to: An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis (Nature Biomedical Engineering, (2023), 8, 10, (1243-1265), 10.1038/s41551-023-01136-9) Au KM, Wilson JE, Ting JP, Wang AZ Nature Biomedical Engineering 2024 Oct 8 1322 Correction to Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis(Adv. Mater., (2022), 34, (2107392), 10.1002/adma.202107392) Au KM, Tisch R, Wang A Advanced Materials 2024 Aug 36 Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis Au KM, Tisch R, Wang AZ Advanced Materials 2022 Feb 34 In Vivo Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus Au KM, Tisch R, Wang AZ ACS Nano 2021 Dec 15 19990-20002 Immune Checkpoint-Bioengineered Beta Cell Vaccine Reverses Early-Onset Type 1 Diabetes Au KM, Medik Y, Ke Q, Tisch R, Wang AZ Advanced Materials 2021 Jun 33 Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models Zhang M, Hagan CT, Foley H, Tian X, Yang F, Au KM, Mi Y, Medik Y, Roche K, Wagner K, Rodgers Z, Min Y, Wang AZ Acta Biomaterialia 2021 Apr 124 327-335 Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy Au KM, Par SI, Wa AZ Science Advances 2020 Jul 6 Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles for treatment of non-Hodgkin’s lymphoma Au KM, Wang AZ, Park SI Science Advances 2020 Apr 6 High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles Au KM, Balhorn R, Balhorn MC, Park SI, Wang AZ ACS Central Science 2019 Jan 5 122-144 Results 1-10 of 22 1 2 3 Next Last Honors & Awards Raleigh Award for Excellence in Biology Research, Department of Radiation Oncology, University of North Carolina (UNC)-Chapel Hill, NC (2020) The Wharton Prize, The University of Sheffield (UK) (2019) Best Poster Award, UK Macro Group 3rd International Polymer Chemistry Conference (2012) The Wharton Prize, University of Sheffield (UK) (2004) Professional Associations/Affiliations American Chemical Society, Member (2007)
